SPL

0.00%

9.9¢ starpharma holdings limited

PLEASE EXPLAIN Jackie Fairley !, page-2

First 2 Last

Share
Profile

Follow
bid

674 Posts.

174

16/06/23

20:39

Post #: 68333225
Share

Originally posted by sarge17: ↑

This 17 year and IMO stale CEO, with one eye on the exit door needs to send a belated and desperately needed update to the market on Monday morning.
With the share price touching 14 year lows today, shareholders deserve honest answers, and nothing less.

For full disclosure, I broke one of Warren Buffett’s golden rules late this afternoon.

Buffet said: “It’s far better to buy a wonderful company at a fair price, than a fair company at a wonderful price”

Despite all my misgivings, I put a toe into the water buying 121,000. And on reflection, Starpharma is less than a fair company. In my opinion it’s an under-performing laggard with serious questions to answer. I’m probably crazy and may regret this decision, but I’ll add more if we go lower, let’s see what happens.

The main impetus to buy was the low enterprise value. There’s still many dangers, traps and hazards ahead, and I still maintain Viraleze and DEP-Docetaxel are commercial duds. There is also a legit risk of a capital raising before EOFY as well IMO.I’m holding out hope for an opportunistic take-over offer or some other positive announcement out of left field.

I’ll continue holding if there is a bonafide positive announcement of substance, whereas I’ll have no hesitation in dumping into a sugar hit price rise based on a fluff announcement.

Anyway, have a good weekend fellow shareholders.

P.S. Personally I would like the Chair and CEO to both resign prior to the AGM and give this company a fresh set of eyes, ears, principles and leadership.

P.S.S. Even though I’m now a shareholder and want my investment to prosper, I will continue to loudly call out any missteps, failures and questionable developments going forward.

Expand

who cares lol

SPL Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

1 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

There are more pages in this discussion • 5 more messages in this thread...

First 2 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.9¢		Change 0.000(0.00%)		Mkt cap ! $41.31M

Open	High	Low	Value	Volume
10.0¢	10.0¢	9.9¢	$14.97K	151.0K

Buyers (Bids)

No.	Vol.	Price($)
3	372123	9.9¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	5042	1

View Market Depth

No.	Vol.	Price($)
3	372123	0.099
2	140000	0.098
1	64565	0.097
1	50000	0.095
3	41738	0.094

Price($)	Vol.	No.
0.100	5042	1
0.105	137318	2
0.110	226808	10
0.115	122327	4
0.120	139405	10

Last trade - 16.10pm 27/09/2024 (20 minute delay)

SPL (ASX) Chart

PLEASE EXPLAIN Jackie Fairley !, page-2

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PLEASE EXPLAIN Jackie Fairley !, page-2

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News